Post-Approval Study

Now enrolling eligible patients in the RNS® System Post-Approval Study (PAS) in Epilepsy at comprehensive epilepsy centers throughout the United States. The objective of the study is to follow patients implanted with the RNS System prospectively over 5 years to gather data on the long-term effectiveness and safety of the RNS System. For more information about the study, contact a NeuroPace Clinical Research Associate at kflynn@neuropace.com or 650-793-5277 .